Document Detail

Intravenous versus intramuscular atropine in ECT.
MedLine Citation:
PMID:  1503142     Owner:  NLM     Status:  MEDLINE    
Twelve patients receiving ECT consented to random assignment to either intravenous or intramuscular administration of atropine for a total of 48 ECTs. There were no statistically significant differences between routes of administration in heart rate, blood pressures, or sialorrhea, but intravenous administration eliminated one injection per treatment and the development of dry mouth and tachycardia between the intramuscular injection and ECT. The authors recommend that atropine for ECT be administered intravenously.
B A Kramer; A Afrasiabi; V E Pollock
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The American journal of psychiatry     Volume:  149     ISSN:  0002-953X     ISO Abbreviation:  Am J Psychiatry     Publication Date:  1992 Sep 
Date Detail:
Created Date:  1992-09-15     Completed Date:  1992-09-15     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370512     Medline TA:  Am J Psychiatry     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1258-60     Citation Subset:  AIM; IM    
Department of Psychiatry, University of Southern California School of Medicine, Los Angeles.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Atropine / administration & dosage*,  adverse effects
Blood Pressure / drug effects
Electroconvulsive Therapy / methods*
Heart Rate / drug effects
Injections, Intramuscular
Injections, Intravenous
Middle Aged
Sialorrhea / chemically induced
Tachycardia / chemically induced
Xerostomia / chemically induced
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Differences in neuropsychological and academic achievement between adolescent delinquents and status...
Next Document:  Creating a healthy public.